Rafael Micán

413 total citations
19 papers, 79 citations indexed

About

Rafael Micán is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Rafael Micán has authored 19 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Rafael Micán's work include HIV Research and Treatment (8 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (7 papers). Rafael Micán is often cited by papers focused on HIV Research and Treatment (8 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (7 papers). Rafael Micán collaborates with scholars based in Spain. Rafael Micán's co-authors include Luz Martı́n-Carbonero, Carmen Busca, Rocío Montejano, Marisa Montes, Juan González‐García, Ignacio Valero, José Ignacio Bernardino, Eulalia Valencia, Lucía Serrano‐Luján and Rosa de Miguel Buckley and has published in prestigious journals such as AIDS, Clinical Microbiology and Infection and Biomedicine & Pharmacotherapy.

In The Last Decade

Rafael Micán

15 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Micán Spain 6 49 35 33 23 19 19 79
Liviana Della Torre Italy 5 54 1.1× 50 1.4× 23 0.7× 11 0.5× 7 0.4× 8 78
Kate El Bouzidi United Kingdom 8 98 2.0× 89 2.5× 59 1.8× 39 1.7× 27 1.4× 15 157
Maurizio Milesi Italy 4 24 0.5× 17 0.5× 17 0.5× 11 0.5× 14 0.7× 5 44
F.P. Antonucci Italy 4 37 0.8× 12 0.3× 36 1.1× 32 1.4× 10 0.5× 10 77
Christine Cheneau France 7 77 1.6× 52 1.5× 29 0.9× 5 0.2× 29 1.5× 10 100
Joseph Eron United States 3 39 0.8× 31 0.9× 17 0.5× 7 0.3× 5 0.3× 4 49
Bao-Chau Phung France 5 22 0.4× 20 0.6× 62 1.9× 42 1.8× 4 0.2× 6 76
S. Chadapaud France 4 12 0.2× 10 0.3× 36 1.1× 28 1.2× 9 0.5× 5 59
Rosemary Schluger United States 2 109 2.2× 96 2.7× 14 0.4× 18 0.8× 12 0.6× 3 125
Arlette Emième Ivory Coast 6 57 1.2× 29 0.8× 63 1.9× 40 1.7× 5 0.3× 9 93

Countries citing papers authored by Rafael Micán

Since Specialization
Citations

This map shows the geographic impact of Rafael Micán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Micán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Micán more than expected).

Fields of papers citing papers by Rafael Micán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Micán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Micán. The network helps show where Rafael Micán may publish in the future.

Co-authorship network of co-authors of Rafael Micán

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Micán. A scholar is included among the top collaborators of Rafael Micán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Micán. Rafael Micán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Micán, Rafael, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2025). Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World. Open Forum Infectious Diseases. 12(3). ofaf087–ofaf087. 1 indexed citations
3.
4.
Buckley, Rosa de Miguel, Carmen Busca, Rafael Micán, et al.. (2024). Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. HIV Medicine. 25(6). 684–691.
5.
6.
Escosa, Luis, José Ignacio Bernardino, Eulalia Valencia, et al.. (2023). Mental Health in Children, Adolescents, and Youths Living with Perinatally Acquired HIV: At the Crossroads of Psychosocial Determinants of Health. Children. 10(2). 405–405. 2 indexed citations
7.
Busca, Carmen, Ángel Robles‐Marhuenda, Mariana Díaz‐Almirón, et al.. (2023). Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIV. AIDS Research and Human Retroviruses. 39(3). 130–135. 2 indexed citations
8.
Marcelo, Cristina, Lucía Serrano‐Luján, Carmen Busca, et al.. (2023). Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(3). 130–134. 1 indexed citations
9.
Buckley, Rosa de Miguel, Rocío Montejano, Carmen Busca, et al.. (2023). Three‐year efficacy of switching to dolutegravir plus lamivudine: A real‐world study. HIV Medicine. 24(9). 1013–1019. 11 indexed citations
10.
Díaz‐Almirón, Mariana, Carmen Busca, Rafael Micán, et al.. (2022). Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study. HIV Medicine. 24(5). 558–567. 2 indexed citations
11.
12.
Martı́n-Carbonero, Luz, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2022). Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(3). 121–124. 1 indexed citations
13.
Virseda‐Berdices, Ana, David Rojo, Isidoro Martínez, et al.. (2022). Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients. Biomedicine & Pharmacotherapy. 147. 112623–112623. 10 indexed citations
14.
Martı́n-Carbonero, Luz, et al.. (2022). Real-world efficacy of switching to bictegravir/ emtricitabine/tenofovir alafenamide in pretreated patients with triple therapy containing rilpivirine. Revista Española de Quimioterapia. 35(4). 378–381. 3 indexed citations
15.
Micán, Rafael, Julen Cadiñanos, Rosa de Miguel Buckley, et al.. (2022). Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients. AIDS. 36(14). 1941–1947. 19 indexed citations
16.
Pérez‐Latorre, Leire, Juan Berenguer, Rafael Micán, et al.. (2021). HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018. Eurosurveillance. 26(25). 6 indexed citations
17.
18.
Asín, María Asunción Pérez‐Jacoiste, Otilia Bisbal, José Antonio Iribarren, et al.. (2020). Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study. Clinical Microbiology and Infection. 27(8). 1171.e1–1171.e7. 3 indexed citations
19.
Martı́n-Carbonero, Luz, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2020). Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades Infecciosas y Microbiología Clínica. 40(3). 121–124. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liviana Della Torre Breakdown of academic impact, for papers by Kate El Bouzidi Breakdown of academic impact, for papers by Maurizio Milesi Breakdown of academic impact, for papers by F.P. Antonucci Breakdown of academic impact, for papers by Christine Cheneau Breakdown of academic impact, for papers by Joseph Eron Breakdown of academic impact, for papers by Bao-Chau Phung Breakdown of academic impact, for papers by S. Chadapaud Breakdown of academic impact, for papers by Rosemary Schluger Breakdown of academic impact, for papers by Arlette Emième
Rankless by CCL
2026